AddLife AB (publ) (ALIF-B.ST)
SEK 137.2
(2.39%)
SEK 137.2
(2.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.77 Billion SEK | -19.08% |
| 2022 | 3.42 Billion SEK | 19.97% |
| 2021 | 2.85 Billion SEK | 57.09% |
| 2020 | 1.81 Billion SEK | 51.76% |
| 2019 | 1.19 Billion SEK | 34.66% |
| 2018 | 889.8 Million SEK | 5.82% |
| 2017 | 840.9 Million SEK | 25.51% |
| 2016 | 670 Million SEK | 22.33% |
| 2015 | 547.7 Million SEK | -10.08% |
| 2014 | 609.1 Million SEK | 62.43% |
| 2013 | 375 Million SEK | 6.17% |
| 2012 | 353.2 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 973 Million SEK | 0.52% |
| 2024 Q3 | 874 Million SEK | -10.17% |
| 2024 Q1 | 968 Million SEK | 5.22% |
| 2023 Q1 | 926 Million SEK | 7.18% |
| 2023 Q3 | 859 Million SEK | -4.02% |
| 2023 Q2 | 895 Million SEK | -3.35% |
| 2023 FY | 2.77 Billion SEK | -19.08% |
| 2023 Q4 | 920 Million SEK | 7.1% |
| 2022 Q4 | 864 Million SEK | 15.05% |
| 2022 Q2 | 811 Million SEK | -18.98% |
| 2022 Q1 | 1 Billion SEK | 28.4% |
| 2022 FY | 3.42 Billion SEK | 19.97% |
| 2022 Q3 | 751 Million SEK | -7.4% |
| 2021 Q4 | 779.6 Million SEK | 18.12% |
| 2021 FY | 2.85 Billion SEK | 57.09% |
| 2021 Q1 | 623 Million SEK | 2.57% |
| 2021 Q2 | 794 Million SEK | 27.45% |
| 2021 Q3 | 660 Million SEK | -16.88% |
| 2020 FY | 1.81 Billion SEK | 51.76% |
| 2020 Q4 | 607.4 Million SEK | 41.26% |
| 2020 Q3 | 430 Million SEK | 4.37% |
| 2020 Q2 | 412 Million SEK | 11.65% |
| 2020 Q1 | 369 Million SEK | 8.79% |
| 2019 Q4 | 339.2 Million SEK | 21.14% |
| 2019 Q1 | 288 Million SEK | 17.65% |
| 2019 Q3 | 280 Million SEK | -3.78% |
| 2019 Q2 | 291 Million SEK | 1.04% |
| 2019 FY | 1.19 Billion SEK | 34.66% |
| 2018 Q2 | 227 Million SEK | 5.09% |
| 2018 FY | 889.8 Million SEK | 5.82% |
| 2018 Q4 | 244.8 Million SEK | 21.19% |
| 2018 Q3 | 202 Million SEK | -11.01% |
| 2018 Q1 | 216 Million SEK | -11.8% |
| 2017 Q2 | 210 Million SEK | 2.44% |
| 2017 FY | 840.9 Million SEK | 25.51% |
| 2017 Q3 | 181 Million SEK | -13.81% |
| 2017 Q1 | 205 Million SEK | -2.1% |
| 2017 Q4 | 244.9 Million SEK | 35.3% |
| 2016 Q2 | 163.9 Million SEK | 54.19% |
| 2016 Q3 | 137.1 Million SEK | -16.35% |
| 2016 Q1 | 106.3 Million SEK | -34.22% |
| 2016 Q4 | 209.4 Million SEK | 52.74% |
| 2016 FY | 670 Million SEK | 22.33% |
| 2015 FY | 547.7 Million SEK | -10.08% |
| 2015 Q3 | 124.3 Million SEK | 21.62% |
| 2015 Q4 | 161.6 Million SEK | 30.01% |
| 2015 Q1 | 315 Million SEK | 180.5% |
| 2015 Q2 | 102.2 Million SEK | -67.56% |
| 2014 FY | 609.1 Million SEK | 62.43% |
| 2014 Q4 | 112.3 Million SEK | 0.0% |
| 2013 FY | 375 Million SEK | 6.17% |
| 2012 FY | 353.2 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Biotage AB (publ) | 1.14 Billion SEK | -141.34% |
| Bonesupport Holding AB (publ) | 533.12 Million SEK | -420.143% |
| Doxa AB (publ) | 9.9 Million SEK | -27910.101% |
| Elekta AB (publ) | 6.77 Billion SEK | 59.082% |
| iZafe Group AB (publ) | 293 Thousand SEK | -946316.382% |
| Ortivus AB (publ) | 30.84 Million SEK | -8891.278% |
| Ortivus AB (publ) | 30.84 Million SEK | -8891.278% |
| Q-linea AB (publ) | 995 Thousand SEK | -278593.467% |
| S2Medical AB (publ) | 5.03 Million SEK | -54952.6% |
| Synsam AB (publ) | 617 Million SEK | -349.433% |